Premium
Bioabsorbable‐polymer drug‐eluting stents in acute myocardial infarction: Insights from the ULLISE registry
Author(s) -
Belardi Jorge,
Lamelas Pablo
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28689
Subject(s) - medicine , myocardial infarction , drug , cardiology , drug eluting stent , clinical trial , acute coronary syndrome , adverse effect , intensive care medicine , percutaneous coronary intervention , pharmacology
Key Points Limited information is available about the performance of bioabsorbable‐polymer drug‐eluting stents in the setting of acute myocardial infarction. Patients treated with these stents presenting with acute myocardial infarction are at higher risk of adverse events compared with stable patients. Further clinical trials are needed to fully understand the role of bioabsorbable‐polymer drug‐eluting stents in patients presenting with acute myocardial infarction.